246 related articles for article (PubMed ID: 30698726)
21. TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.
Guiho R; Biteau K; Grisendi G; Taurelle J; Chatelais M; Gantier M; Heymann D; Dominici M; Redini F
Int J Cancer; 2016 Dec; 139(12):2802-2811. PubMed ID: 27558972
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
Clifton KB; Conover CA
Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
[TBL] [Abstract][Full Text] [Related]
23. VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma.
Englisch A; Altvater B; Kailayangiri S; Hartmann W; Rossig C
Pediatr Blood Cancer; 2020 Oct; 67(10):e28313. PubMed ID: 32729251
[TBL] [Abstract][Full Text] [Related]
24. Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
Smith YE; Toomey S; Napoletano S; Kirwan G; Schadow C; Chubb AJ; Mikkelsen JH; Oxvig C; Harmey JH
BMC Cancer; 2018 Oct; 18(1):1016. PubMed ID: 30348128
[TBL] [Abstract][Full Text] [Related]
25. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
26. Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma.
Dallmayer M; Li J; Ohmura S; Alba Rubio R; Baldauf MC; Hölting TLB; Musa J; Knott MML; Stein S; Cidre-Aranaz F; Wehweck FS; Romero-Pérez L; Gerke JS; Orth MF; Marchetto A; Kirchner T; Bach H; Sannino G; Grünewald TGP
Cell Death Dis; 2019 Feb; 10(2):116. PubMed ID: 30741933
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo.
Boldt HB; Conover CA
Endocrinology; 2011 Apr; 152(4):1470-8. PubMed ID: 21303951
[TBL] [Abstract][Full Text] [Related]
28. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy associated plasma protein-A knock-out mice.
Mason EJ; Grell JA; Wan J; Cohen P; Conover CA
Growth Horm IGF Res; 2011 Oct; 21(5):243-7. PubMed ID: 21802327
[TBL] [Abstract][Full Text] [Related]
30. Cellular characterization of human epicardial adipose tissue: highly expressed PAPP-A regulates insulin-like growth factor I signaling in human cardiomyocytes.
Conover CA; Bale LK; Frye RL; Schaff HV
Physiol Rep; 2019 Feb; 7(4):e14006. PubMed ID: 30809969
[TBL] [Abstract][Full Text] [Related]
31. EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.
Chakraborty S; Bhat AM; Mushtaq I; Luan H; Kalluchi A; Mirza S; Storck MD; Chaturvedi N; Lopez-Guerrero JA; Llombart-Bosch A; Machado I; Scotlandi K; Meza JL; Ghosal G; Coulter DW; Jordan Rowley M; Band V; Mohapatra BC; Band H
Commun Biol; 2023 Jul; 6(1):758. PubMed ID: 37474760
[TBL] [Abstract][Full Text] [Related]
32. Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis.
Tanaka Y; Kobayashi H; Suzuki M; Hirashima Y; Kanayama N; Terao T
Int J Cancer; 2004 Apr; 109(3):336-47. PubMed ID: 14961570
[TBL] [Abstract][Full Text] [Related]
33. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis.
Marques Howarth M; Simpson D; Ngok SP; Nieves B; Chen R; Siprashvili Z; Vaka D; Breese MR; Crompton BD; Alexe G; Hawkins DS; Jacobson D; Brunner AL; West R; Mora J; Stegmaier K; Khavari P; Sweet-Cordero EA
J Clin Invest; 2014 Dec; 124(12):5275-90. PubMed ID: 25401475
[TBL] [Abstract][Full Text] [Related]
35. A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts.
Becker MA; Haluska P; Bale LK; Oxvig C; Conover CA
Mol Cancer Ther; 2015 Apr; 14(4):973-81. PubMed ID: 25695953
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
Sun IY; Overgaard MT; Oxvig C; Giudice LC
J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
[TBL] [Abstract][Full Text] [Related]
37. Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo.
Pan H; Hanada S; Zhao J; Mao L; Ma MZ
PLoS One; 2012; 7(11):e48799. PubMed ID: 23152806
[TBL] [Abstract][Full Text] [Related]
38. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
Resch ZT; Simari RD; Conover CA
Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
[TBL] [Abstract][Full Text] [Related]
39. Lack of functional pregnancy-associated plasma protein-A (PAPPA) compromises mouse ovarian steroidogenesis and female fertility.
Nyegaard M; Overgaard MT; Su YQ; Hamilton AE; Kwintkiewicz J; Hsieh M; Nayak NR; Conti M; Conover CA; Giudice LC
Biol Reprod; 2010 Jun; 82(6):1129-38. PubMed ID: 20130263
[TBL] [Abstract][Full Text] [Related]
40. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
